You just read:

Takeda Receives Positive CHMP Opinion for Entyvio® (vedolizumab) in Europe for the Treatment of Ulcerative Colitis and Crohn's Disease

News provided by

Takeda Pharmaceutical Company Limited

21 Mar, 2014, 12:38 GMT